Abbott price target raised to $85 from $75 at Jefferies Jefferies raised its price target for Abbott after estimating AbbVie's valuation at $55 per share. The firm says Abbott remains its top pick through 2012.
News For ABT From The Last 14 Days
Check below for free stories on ABT the last two weeks.
Abbott upgraded to Buy from Neutral at Goldman Goldman upgraded Abbott to reflect accelerating growth driven by emerging markets, better growth and product mix, new product launches, and market share gains. Price target raised to $44 from $38.